Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms

Abstract

The nucleotide-binding domain and leucine-rich repeat protein 3 (NLRP3), an intracellular signaling molecule that senses many environmental- and pathogen/host-derived factors, has been implicated in the pathogenesis of several diseases associated with inflammation. It has been suggested that NLRP3 inflammasome inhibitors may have a therapeutic potential in the treatment of NLRP3-related inflammatory diseases. The aim of this study was to determine whether inhibition of NLRP3 inflammasome prevents inflammatory hyperalgesia induced by lipopolysaccharide (LPS) in mice as well as changes in expression/activity of nuclear factor κB (NF-κB), caspase-1/11, nicotinamide adenine dinucleotide phosphate oxidase (NOX), and endothelial/neuronal/inducible nitric oxide synthase (eNOS/nNOS/iNOS) that may regulate NLRP3/apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC)/pro-caspase-1 inflammasome formation and activity by using a selective NLRP3 inflammasome inhibitor, MCC950. Male mice received saline (10 ml/kg; i.p.), LPS (10 mg/kg; i.p.), and/or MCC950 (3 mg/kg; i.p.). Reaction time to thermal stimuli within 1 min was evaluated after 6 h. The mice were killed and the brains, hearts, and lungs were collected for measurement of NF-κB, caspase-1, caspase-11, NLRP3, ASC, NOX subunits (gp91; NOX2), and p47; NOXO2), nitrotyrosine, eNOS, nNOS, iNOS, and β-actin protein expression, NOS activity, and interleukin (IL)-1β levels. LPS-induced hyperalgesia was associated with a decrease in eNOS, nNOS, and iNOS protein expression and activity as well as an increase in expression of NF-κB p65, caspase-1 p20, caspase-11 p20, NLRP3, ASC, gp91, p47, and nitrotyrosine proteins in addition to elevated IL-1β levels. The LPS-induced changes were prevented by MCC950. The results suggest that inhibition of NLRP3/ASC/pro-caspase-1 inflammasome formation and activity prevents inflammatory hyperalgesia induced by LPS in mice as well as changes in NF-κB, caspase-11, NOX2, NOXO2, and eNOS/nNOS/iNOS expression/activity.

Epigallocatechin‐3‐Gallate Attenuates Microglial Inflammation and Neurotoxicity by Suppressing the Activation of Canonical and Noncanonical Inflammasome via TLR4/NF‐κB Pathway

“…TLR4/NF‐κB signaling pathway was reported to be involved in the pathogenesis of AD, and the NF‐κB signaling cascade was a necessary prerequisite for the activation of both canonical and noncanonical inflammasome according to previous research . We then examined whether EGCG treatment regulated TLR4/NF‐κB pathway in LPS+Aβ‐induced BV2 cells.…”

Melatonin alleviates intervertebral disc degeneration by disrupting the IL-1β/NF-κB-NLRP3 inflammasome positive feedback loop

“…Dolunay et al showed that the inhibition of NLRP3/ASC/pro-caspase-1 inflammasome formation and activity prevents LPS-induced inflammatory hyperalgesia in mice. 54,55 However, whether IL-1β activates the NLRP3 inflammasome has seldom been studied. In this study, we showed for the first time that in NP cells, IL-1β treatment activated the NLRP3 inflammasome in time-and dose-dependent manners.…”

Interleukin-1β is a potential therapeutic target for periodontitis: a narrative review

“…MCC950 blocks ASC oligomerization and the activation of caspase-1 and IL-1β in mouse and human macrophages. 135 Thus, MCC950 reduces IL-1β production and may serve as a potential target for inflammatory diseases [136][137][138] It also provides protection against injury. MCC950 significantly reduces the development of atherosclerotic lesions, cardiac infarction and brain injury after intracerebral haemorrhage in mice.…”